Buy BPCL, India Cements, UPL; Aurobindo Pharma may hit Rs 700: Ashwani Gujral

Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "Aurobindo Pharma is going through a sharp rally and Rs 700 is the 200-day moving average, so, that is a nice target. It is possible that it has bottomed out but possibly a correction from Rs 700 will tell us whether that has happened. So, I would think that a target of Rs 700 should be likely on Aurobindo Pharma."

"India Cements is a buy with a stop loss of Rs 212 and target of Rs 226. UPL is also a buy with a stop loss of Rs 865 and target of Rs 900. BPCL yesterday was at its 200-day moving average. So, today’s upside has a very close stop. That is often good for traders. BPCL is a buy with a stop losss of Rs 680 and target of Rs 705," he said.